TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.750
AS - Asia 1.665
EU - Europa 1.465
SA - Sud America 396
AF - Africa 44
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.324
Nazione #
US - Stati Uniti d'America 2.674
SG - Singapore 694
CN - Cina 415
IT - Italia 330
BR - Brasile 314
RU - Federazione Russa 266
DE - Germania 261
HK - Hong Kong 240
IE - Irlanda 197
SE - Svezia 128
VN - Vietnam 119
GB - Regno Unito 52
CA - Canada 46
FI - Finlandia 44
AT - Austria 40
AR - Argentina 31
IN - India 29
FR - Francia 26
KR - Corea 26
UA - Ucraina 26
TR - Turchia 25
ZA - Sudafrica 23
NL - Olanda 22
ID - Indonesia 21
JP - Giappone 19
MX - Messico 19
PL - Polonia 19
BD - Bangladesh 18
EC - Ecuador 18
ES - Italia 17
PK - Pakistan 12
DK - Danimarca 11
EG - Egitto 11
CL - Cile 9
IQ - Iraq 9
CO - Colombia 6
IL - Israele 6
PY - Paraguay 6
UZ - Uzbekistan 6
LT - Lituania 5
SA - Arabia Saudita 5
VE - Venezuela 5
AL - Albania 4
CZ - Repubblica Ceca 4
IR - Iran 4
JO - Giordania 4
PH - Filippine 4
AU - Australia 3
BE - Belgio 3
MA - Marocco 3
PE - Perù 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
PA - Panama 2
RO - Romania 2
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
SV - El Salvador 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.324
Città #
Ann Arbor 509
Singapore 449
Ashburn 279
Hong Kong 240
Chandler 196
Dublin 192
Frankfurt am Main 185
Woodbridge 167
Fairfield 129
New York 90
Wilmington 90
Beijing 88
Dallas 84
Los Angeles 69
Milan 68
Hefei 58
Houston 52
Seattle 50
Princeton 48
Shanghai 48
Santa Clara 43
Cambridge 41
Jacksonville 40
Ho Chi Minh City 38
The Dalles 37
Lissone 34
Hanoi 33
Moscow 33
Munich 33
São Paulo 33
Dearborn 30
Vienna 28
Seoul 26
Buffalo 25
Altamura 23
Lawrence 22
Chicago 20
Jakarta 17
Nanjing 17
Turku 17
Brooklyn 16
Warsaw 16
Tokyo 15
London 13
Montreal 12
Nuremberg 12
Helsinki 11
Johannesburg 11
Lachine 11
Ottawa 11
Columbus 10
Rio de Janeiro 10
Rome 10
San Diego 10
Andover 9
Boardman 9
Caronno Pertusella 9
Toronto 9
Brasília 8
Hangzhou 8
Xi'an 8
Belo Horizonte 7
Campinas 7
Changsha 7
Chennai 7
Curitiba 7
Denver 7
Guangzhou 7
Mexico City 7
Orem 7
Pavia 7
Phoenix 7
San Francisco 7
Shenyang 7
Stockholm 7
Alexandria 6
Cape Town 6
Charlotte 6
Jinan 6
Melzo 6
Roubaix 6
Tashkent 6
Bologna 5
Boston 5
Council Bluffs 5
Detroit 5
Florence 5
Kent 5
Lahore 5
Lappeenranta 5
Pune 5
Quito 5
Salt Lake City 5
Santo André 5
Tampa 5
Tel Aviv 5
Ankara 4
Atlanta 4
Bellaria-Igea Marina 4
Buenos Aires 4
Totale 4.135
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 300
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 299
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 266
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 257
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 238
Neutrophil Extracellular Traps in the Autoimmunity Context 234
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 225
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 224
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 219
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 218
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 216
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 206
Novel Therapies in Takayasu Arteritis 206
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 187
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 185
Immunology of membranous nephropathy: From animal models to humans 184
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 181
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 177
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 169
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 167
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 164
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 161
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 158
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 158
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 157
Evidence for charge-based mimicry in anti dsDNA antibody generation 155
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 152
ANCA-associated vasculitides (AAV) from the gender point of view 152
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 146
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 134
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 133
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 132
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 116
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 112
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 91
Totale 6.479
Categoria #
all - tutte 22.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 65 76 41 52 75 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20261.856 442 208 305 406 455 40 0 0 0 0 0 0
Totale 6.479